menu
    • menu

    Company profile for Arrakis Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arrakis has a simple but powerful vision: To extend small-molecule medicines into new realms of biology, unlocking that biology for medicine. Our approach builds on the existing sophisticated drug discovery toolkit developed for protein targets, which we are adapting and refocusing on discovering small-molecule compounds that act directly on RNA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arrakis TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    830 Winter Street Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://arrakistx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arrakis To Present RNA-Targeted Drug For Myotonic Dystrophy At MDA
    Arrakis To Present RNA-Targeted Drug For Myotonic Dystrophy At MDA

    10 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310288419/en

    BUSINESSWIRE
    10 Mar 2025
    Share Share
    Arrakis Unveils Data On RNA-Targeted Drug For Myotonic Dystrophy
    Arrakis Unveils Data On RNA-Targeted Drug For Myotonic Dystrophy

    04 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241204164255/en

    BUSINESSWIRE
    04 Dec 2024
    Share Share
    RNA-targeting drug relaxes muscles in myotonic dystrophy mice
    RNA-targeting drug relaxes muscles in myotonic dystrophy mice

    04 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/rna-targeting-molecule-arrakis-allows-muscles-relax-mice-myotonic-dystrophy

    FIERCE BIOTECH
    04 Dec 2024
    Share Share
    Arrakis Therapeutics reduces headcount by 20%
    Arrakis Therapeutics reduces headcount by 20%

    01 Mar 2024

    // Kyle LaHucik ENDPTS

    https://endpts.com/arrakis-therapeutics-reduces-headcount-by-20/

    Kyle LaHucik ENDPTS
    01 Mar 2024
    Share Share
    Arrakis Therapeutics to Present at Jefferies Healthcare Conference
    Arrakis Therapeutics to Present at Jefferies Healthcare Conference

    01 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220601005079/en

    BUSINESSWIRE
    01 Jun 2022
    Share Share
    Arrakis Therapeutics to Participate in Upcoming May Investor Conferences
    Arrakis Therapeutics to Participate in Upcoming May Investor Conferences

    10 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220510005378/en

    BUSINESSWIRE
    10 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search